1[1]Baron S, Tyring S K, Fleischmann W R, et al. The interferons : mechanisms of action and clinical applications. JAMA, 1991,266(10): 1375～ 1383 被引量：1
2[2]Comell R C,Greenway H T,Tucker SB,et al. Intralesional interferon therapy for basal cell carcinoma. J Am Acad De rmatol,1990,23(4 pt) :694～700 被引量：1
3[3]Perrillo R P,Schiff E R,Davis G L,et al. A randomized controlled trial of interferon alpha- 2b alone and after prednisone with drawal for the treatment of chronic hepatitis B. N Engl J Med,1990,323(5):2955～301 被引量：1
4[4]Marelli A, Nardecchia L, de Gennaro F,et al. Therapy of chronic hepatitis C with alpha- interferferon in 182patients. evaluation of results, response predictive factors and side effectsp. Minerva Med,1999,90(11- 12) :405～412 被引量：1
5[5]Omata M, Yokosuka O, Takano S,ea al. Resolution of actute hepatitis C after therapy with natural betainterferon. Recent Prog Med, 1998,89 (5): 55～ 62 被引量：1
6[6]Vezzoli M ,Girola S,Fossati G ,et al. Beta- Interferon the rapy of chronic hepatitis HCV +, lb genontype. Recent Prog Med ,1998,89(5) :235～240 被引量：1
7[7]Di Bisceglie AM,Rustgi VK,Kassianides C,et al. Therapy of chronic hepatitis B with recombiant human alpha and gamma interferon. Hepatology, 1990,11 (2) .. 266 ～ 270 被引量：1
8[8]Veys EM, Menkes C J, Emery P, et al. A randomized double blind study comparing twenty- four- week treatment with recombinant interferon and versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum, 1997,40(1): 62～68 被引量：1
